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1 
Abstract 
 
Rates of labor induction and augmentation have been increasing in recent 
decades (Glantz, 2005). According to the Listening to Mothers II survey, half of all 
labors in the U.S. are induced or augmented with Pitocin or other synthetic form of the 
hormone oxytocin (Declercq et al., 2006). Oxytocin, a naturally occurring hormone released 
in the pituitary gland, is involved in the stimulation of uterine contractions during labor and 
in the milk ejection reflex during breastfeeding, and research suggests it also has various 
effects on the brain, such as eliciting maternal behavior. However, studies have shown that 
exogenous oxytocin can interfere with the natural production and regulation of oxytocin and 
can have adverse effects on the fetus and mother. Therefore, I predict that the induction or 
augmentation of labor with Pitocin will negatively affect breastfeeding following birth. The 
proposed study will compare LATCH scores, used in hospitals to measure postpartum 
breastfeeding success, of dyads exposed to intravenous Pitocin prior to birth with control 
dyads that had no exposure to Pitocin during labor. It is hypothesized that dyads exposed to 
Pitocin will have significantly lower LATCH scores than controls. Given the countless health 
benefits of breastfeeding for both mother and infant, the results of this study will have 
important implications for the evaluation of common practices during labor and birth.  
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Introduction  
 The use of drugs and other interventions during labor and birth in the U.S. is 
becoming increasingly common. One such intervention is induction of labor for either 
elective reasons, such as discomfort from pregnancy or for convenience, or due to medical 
reasons, such as preeclampsia (high blood pressure) or gestational diabetes when it is deemed 
medically necessary to deliver the baby. In spontaneous labor, the naturally occurring 
hormone oxytocin helps stimulate uterine contractions, whereas for most labor inductions, a 
synthetic form of oxytocin is administered intravenously in order to artificially stimulate 
contractions (the brand names of synthetic oxytocin include both Pitocin and Syntocinon, but 
for simplicity it will be referred to here as Pitocin). Pitocin is also used to augment labor that 
is not progressing quickly enough, and it is often injected intramuscularly following delivery 
during the third stage of labor to prevent post-partum hemorrhage. According to the 
Listening to Mothers II survey, 50% of women giving birth in hospitals in the U.S. received 
Pitocin for either induction or augmentation of labor (Declercq et al., 2006).  
 Although induction or augmentation with Pitocin is regarded by many hospitals as a 
relatively safe and routine intervention, Pitocin can have different physiological effects on 
the mother and fetus than endogenous oxytocin. These effects can interfere with 
breastfeeding in the early postpartum period, potentially having an adverse effect on long-
term breastfeeding success and thus the overall health of the mother and infant.  
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The Physiology of Oxytocin  
 Naturally occurring in all mammals, oxytocin is a peptide hormone that has various 
effects on both the brain and peripheral systems during and after birth. It is produced in the 
magnocellular nuclei of the supraoptic nucleus (SON) and paraventricular nucleus (PVN) of 
the hypothalamus, and it is stored in and released into circulation from the posterior pituitary 
gland (reviewed in von Bohlen und Halbach and Dermietzel, 2002) (Figure 1). In addition to 
acting as a hormone in the peripheral system, oxytocin is also released directly in the central 
nervous system from the cell bodies and dendrites of oxytocin-producing neurons to act as a 
neuromodulator in areas of the brain containing oxytocin receptors, such as the amygdala and 
Figure 1. Oxytocin release from the hypothalamus and posterior pituitary (Silverthorn et al., 2013) 
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hippocampus (Jonas, 2009; von Bohlen und Halbach and Dermietzel, 2002). Oxytocin 
release is controlled by a positive feedback mechanism; for example, oxytocin release in the 
PVN stimulates further release of oxytocin by neurons in the same region (reviewed in 
Kendrick, 2000).  
Once oxytocin is released, it binds to oxytocin receptors (OTRs) located in neural 
tissue in the central nervous system and in the myoepithelial (smooth muscle) cells of the 
uterus and mammary glands in the peripheral system (Leng et al., 2008). OTRs are G-
coupled receptors, and the binding of oxytocin to OTRs on these myoepithelial cells causes a 
rise in intracellular calcium levels to facilitate contraction of the smooth muscle tissue (von 
Bohlen und Halbach and Dermietzel, 2002).  
 
The Role of Oxytocin in Labor and Birth  
During labor and birth, the primary role of oxytocin is to bind to OTRs on the uterus 
to stimulate uterine contractions, which helps expel the fetus from the womb. Once labor 
begins, oxytocin release is regulated by a positive feedback mechanism in which pressure 
from the head of the fetus on the cervix and vagina creates a reflex (called the Fergusson 
reflex) that travels primarily via the pelvic and vagal nerves, spinal cord, and brainstem 
nuclei to stimulate the release of oxytocin from the posterior pituitary (Kendrick, 2000). This 
release of oxytocin then stimulates more uterine contractions, leading to more pressure on the 
cervix and vagina, and so on until the fetus is delivered (Figure 2). The release of oxytocin 
and the resulting uterine contractions occur in pulses approximately 4-8 minutes apart, 
becoming closer together as labor progresses until a peak in oxytocin at the time of delivery 
helps expel the baby from the uterus and birth canal (Fuchs et al., 1991).  
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Figure 2. The Ferguson reflex (Silverthorn et al., 2013) 
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Facilitated by rising estrogen levels, uterine OTRs increase in number and sensitivity 
leading up to the time of parturition, and evidence suggests that the onset of labor is related 
more to the increased sensitivity of these receptors than to increased circulating levels of 
oxytocin (Blanks and Thornton, 2003; Jonas, 2009; Soloff et al., 1979). This change in 
uterine OTRs is also accompanied by an increase in the production of OTRs in the 
hypothalamus and other areas of the brain (e.g. olfactory bulbs and the amygdala) on the day 
of parturition so that these neurons are more sensitive to the release of oxytocin (reviewed in 
Leng et al., 2008). Thus as the body prepares for delivery of the baby, it becomes more 
physiologically receptive to the stimulatory effects of oxytocin during labor and birth. 
 
The Role of Oxytocin in Lactation 
 In addition to the role of oxytocin in the stimulation of uterine contractions during 
labor and delivery, oxytocin continues to play an important role in lactation after birth. 
Stimulation of the nipple by suckling sends a signal via the spinal cord to the hypothalamus 
to induce the release of oxytocin from the pituitary into circulation (Neumann et al., 1996). 
The oxytocin then binds to OTRs on the smooth muscle cells of alveoli in the mammary 
glands, causing them to contract and eject milk into the ducts and cisterns in what is referred 
to as the milk ejection reflex (Figure 3). Just as OTRs in the uterus become more sensitive to 
oxytocin prior to birth, the sensitivity of OTRs in the mammary glands also increases leading 
up to delivery to make the mother more physiologically responsive to circulating oxytocin 
(Soloff et al., 1979). Furthermore, by binding to OTRs on prolactin-releasing cells in the 
anterior pituitary gland, oxytocin also stimulates the release of prolactin, a hormone 
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responsible for milk production (Jonas, 2009). Thus oxytocin plays a crucial role not only in 
labor and delivery, but also in lactation following birth.  
Figure 3. The milk ejection reflex (Silverthorn et al., 2013) 
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The Role of Oxytocin in the Brain 
 In addition to oxytocin’s functions in the uterus and mammary glands, it has been 
found to act on the brain to influence maternal and bonding behaviors. For example, 
intracerebroventricular (ICV) infusions of oxytocin can elicit maternal behaviors in virgin 
animals in as little as 30 seconds, and oxytocin antagonists can inhibit maternal behaviors in 
animals following delivery of their offspring. In sheep, ICV infusions of oxytocin facilitate 
olfactory recognition of offspring following birth (reviewed in Kendrick, 2000), and 
evidence for oxytocin’s role in the onset of maternal behavior has also been found in 
primates (Kendrick, 2000; Saltzman and Maestripieri, 2011). Furthermore, oxytocin has been 
found to affect social bonding in animals. After mating, prairie voles are known to form 
strong pair-bonds with their mates, and pair-bonding can be elicited in these animals 
following ICV infusions of oxytocin even when no mating has occurred (reviewed in 
Kendrick, 2000).  
 The behavioral effects of oxytocin in the human brain are more difficult to study, as 
ICV infusions cannot be performed for ethical reasons, but evidence suggests that oxytocin 
influences maternal behaviors in humans. Oxytocin concentrations in cerebrospinal fluid 
increase during labor, indicating its release in the brain, and increased plasma concentrations 
of oxytocin following birth are associated with positive feelings and reduced anxiety 
(reviewed in Kendrick, 2000). It is possible that these effects may facilitate early 
breastfeeding by making the new mother more relaxed and confident in her ability to 
successfully nurse her infant.  
As discussed, oxytocin plays an important role before, during, and after delivery by 
stimulating uterine contractions to facilitate expulsion of the fetus from the womb, by 
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stimulating the milk ejection reflex, and by influencing maternal behaviors following birth. 
However, administering exogenous oxytocin intravenously can affect the body differently 
than endogenous oxytocin and can have adverse effects on the mother and infant.  
 
Characteristics of Pitocin 
 When Pitocin is used for induction or augmentation of labor, it is administered as a 
continuous intravenous drip, usually starting with small doses (0.5-1 mU/min) and gradually 
increasing the dose every 30-60 minutes until adequate uterine activity is established 
(“Pitocin,” 2009), although specific dosage and protocols often vary by hospital (Miller, 
2009). While Pitocin is similar to endogenous oxytocin in that it binds OTRs on the uterus to 
produce contractions, there are differences in its effects on the body. According to some 
research, infusion rates of up to 6 mU/min lead to the same plasma concentrations that occur 
during spontaneous labor (“Pitocin,” 2009). However, whereas endogenous oxytocin is 
released in pulses every 4-8 minutes, intravenous Pitocin is administered as a continuous 
drip. Next, natural labor involves the release of ß-endorphin, an endogenous opioid also 
produced in the hypothalamus. ß-endorphin helps block pain and regulates the release of 
oxytocin to manage the pace and intensity of labor (Keverne and Kendrick, 1994), but 
continuously administered Pitocin is not subject to this natural regulation. In addition, the 
sensitivity of OTRs can vary greatly between women, so even a standard dose of Pitocin can 
affect individual women differently (“Pitocin,” 2009). In fact, one study measured plasma 
concentrations of oxytocin during intravenous infusion and found no association between 
plasma levels and uterine pressure, suggesting that the intensity of contractions may have 
more to do with OTR sensitivity than with circulating levels of oxytocin (Perry et al., 1996). 
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So although hospitals usually administer standard doses of Pitocin designed to match the 
levels of oxytocin in spontaneous labor, the variation in sensitivity to Pitocin will thus cause 
variation in how each patient reacts to the drug. And while hospitals do often monitor uterine 
contractions and adjust doses accordingly, exogenous Pitocin is not subject to the 
endogenous mechanisms that regulate oxytocin release.  
 One consequence of this lack of natural physiological regulation of exogenous 
oxytocin release is uterine contractions that are stronger, more painful, and closer together, 
with increased uterine resting tone between contractions (e.g. Buckley, 2002; Miller, 2009; 
Kroeger, 2004). One study measured various characteristics of uterine contractions, including 
pressure and duration, in spontaneous and augmented labors and found that on average, 
contractions stimulated by intravenous oxytocin are stronger and have a different wave form 
than spontaneous contractions, indicating that Pitocin affects the body differently than 
endogenous oxytocin (Seitchik and Chatkoff, 1976). Additionally, if doses are improperly 
administered, uterine hyperstimulation can occur, potentially leading to uterine rupture in 
severe cases (Ibrahim, 2009; “Pitocin,” 2009). This is one reason why synthetic oxytocin is 
listed as one of the Institute for Safe Medication Practices’ high alert medications (Miller, 
2009), which are medications that have a greater risk of causing significant patient harm if 
used improperly (ISMP, 2011).  
  The effects of intravenous oxytocin on the brain and behavior are not well 
understood, and there is a lack of research on the effects of Pitocin on maternal behavior. 
Oxytocin, whether naturally released from the posterior pituitary or administered in its 
synthetic form as Pitocin, cannot cross the blood-brain barrier to enter the brain (Lothian, 
2005). Although synthetic oxytocin can reach the brain when administered intranasally, the 
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mechanism for intranasal delivery is different than that of intravenous delivery. When a drug 
is administered intranasally, it can travel through the fluid-filled perineural channels created 
by the cells ensheathing the olfactory receptor neurons, which go through the cribriform plate 
in the skull to directly reach the central nervous system (Dhuria et al., 2010). However, when 
oxytocin is given intravenously, the blood-brain barrier would prevent any significant 
amount of the drug from reaching the brain. It is possible, however, that oxytocin levels in 
the CNS are different when labor is induced than when it begins spontaneously. As 
previously discussed, the mechanism by which oxytocin is released directly into the brain is 
different than the mechanism by which it is released into circulation from the posterior 
pituitary. Studies in rats and sheep found that peripheral levels of oxytocin do not always 
correlate with levels in the brain, suggesting that the two systems may be controlled 
independently (reviewed in Saltzman and Maestripieri, 2011). Therefore, although uterine 
contractions produced by Pitocin would activate the Fergusson reflex in order to stimulate 
the release of oxytocin into circulation from the posterior pituitary, intravenous Pitocin does 
not necessarily cause a rise in oxytocin levels within the brain, especially in cases of labor 
induction when the body has not initiated the release of oxytocin on its own. If it is true that 
Pitocin administered for induction or augmentation is associated with lower levels of 
oxytocin released in the central nervous system, there may not be the same effects on 
maternal behavior (e.g. reduced anxiety) that are associated with the natural release of 
oxytocin in the central nervous system. However, there are currently no known studies 
directly examining the effect of Pitocin on the release of oxytocin within the brain. 
 Although there is no direct evidence that Pitocin affects oxytocin release within the 
brain, evidence from a study on the release of ß-endorphin in the brain during labor does 
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suggest that augmentation of labor with exogenous oxytocin affects the brain differently than 
natural labor (Genazzani et al., 1985). As previously discussed, ß-endorphin helps regulate 
the release of oxytocin during spontaneous labor, and ß-endorphin levels rise in relation to 
the frequency and intensity of uterine contractions, binding to opioid receptor sites on the 
uterus to reduce contractions and relieve some of the pain associated with labor. In the study, 
blood samples taken from women with spontaneous labor were compared to those requiring 
augmentation to treat uterine hypocontractility. It was found that while ß-endorphin levels 
rose significantly throughout labor until the time of delivery in women with spontaneous 
labor, the levels remained constant in women with augmented labor and were 30% lower at 
the time of delivery (Genazzani et al., 1985). Although the authors point out that the lack of a 
rise in these hormones could have been related to the uterine hypocontractility itself rather 
than an effect of intravenous oxytocin, their results are consistent with those of another study 
which found that oxytocin inhibits the release of adrenocorticotropic hormone (ACTH) 
(reviewed in Genazzani et al., 1985). ACTH is another hypothalamic hormone that regulates 
the release of cortisol in response to stress, and like ß-endorphin, it is regulated by 
corticotropin releasing factor (CRF). The authors postulate that intravenous synthetic 
oxytocin causes a decrease in both ß-endorphin and ACTH by interfering with the release of 
CRF (Genazzani et al., 1985), indicating that Pitocin does affect the normal functioning of 
the central nervous system by inhibiting the release of other hormones. In addition, because 
ß-endorphin helps reduce contractions, the lack of a rise in ß-endorphin levels after 
administration of intravenous oxytocin may help explain why the drug often produces 
stronger and more frequent uterine contractions (Genazzani et al., 1985).  
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 While Pitocin does mimic endogenous oxytocin by binding to OTRs to stimulate 
uterine contractions during labor, the evidence described suggests that Pitocin affects the 
body differently than endogenous oxytocin and that it can interfere with the release of other 
hormones. Further evidence described below suggests that these differences in the way 
Pitocin affects the body can lead to negative effects on the neonate and the mother that may 
interfere with breastfeeding success.  
 
The Effects of Pitocin on the Mother, Newborn, and Breastfeeding 
Pitocin can affect the mother and infant in ways that can potentially interfere with 
breastfeeding success. First, the strong and frequent contractions produced by Pitocin can 
cause hyperstimulation of the uterus and can have adverse effects on the fetus, such as 
reduced blood flow (Buckley, 2002). In a study measuring the association between umbilical 
artery pH and uterine activity, it was found that fetal acidosis (defined as umbilical artery pH 
of 7.11 or less), which can be a reflection of poor fetal oxygenation, was significantly 
associated with higher uterine activity (Bakker et al., 2007). This finding is notable, as even a 
slightly reduced blood pH can lead to problems in the newborn, including a greater 
likelihood of requiring assisted ventilation (Bakker et al., 2007). Furthermore, it has been 
suggested that the strong contractions resulting from induction or augmentation can put more 
pressure on the occipital portion of the fetus’ head, potentially increasing the risk for cranial 
molding, asymmetry, and cranial base misalignment, all of which could negatively impact 
the functioning of the six cranial nerves involved in sucking and swallowing during 
breastfeeding (Kroeger, 2004).  
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Next, induction has been found to be associated with lower Apgar scores, which may 
be related to the effects described above. At 1 and 5 minutes after birth, a newborn is 
assigned an Apgar score from 0-10 based on its heart rate, breathing effort, reflexes, muscle 
tone, and skin color; a score of 7 or higher indicates that the infant is in good condition, 
whereas a lower score indicates that the infant may need more medical attention (Zieve and 
Kaneshiro, 2011). Although some studies have found no effect of induction or augmentation 
on Apgar scores (Ounsted et al., 1978; Belsky, 1982), others have found significant effects. 
One study found that a 1-minute Apgar score of ≤3 was significantly more likely after 
elective induction than after spontaneous labor (Beebe et al., 2007), and an analysis of 8 
Latin American countries from the World Health Organization (WHO) Global Survey for 
Maternal and Perinatal Health found that infants born to mothers whose labor was induced 
had twice the risk of a 5-minute Apgar score of <7 compared to those who were not induced 
(Guerra et al., 2009). Low Apgar score can potentially interfere with breastfeeding, as Dewey 
et al. (2003) found that a 1-minute Apgar score of <7 was associated with increased risk of 
suboptimal infant breastfeeding behavior (SIBB) 3 days after birth, and a similar study with a 
different population found that after adjusting for other factors, a 1-minute Apgar score of <8 
was the main predictor of delayed onset of lactogenesis (OL) (Matias et al., 2010). Although 
evidence varies, this research suggests that induction of labor can potentially affect the fetus 
enough to result in a lower Apgar score, which can in turn put the mother-infant dyad at 
greater risk for breastfeeding problems.  
Other adverse neonatal outcomes associated with induction or augmentation of labor 
include hyperbilirubinemia, or jaundice, neonatal resuscitation, shoulder dystocia (failure of 
the infant’s shoulders to pass through the pubic bone during delivery), admission to a 
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neonatal special care unit, and abnormal fetal heart rate (e.g. bradycardia) (Cartwright 1979; 
Romano and Lothian 2008; Ounsted et al., 1978; Glantz, 2005; Belsky, 1982; Yudkin et al., 
1979). Because successful breastfeeding requires the infant to be motivated and alert with 
coordinated sucking and swallowing, these outcomes, which can cause increased stress for 
the infant and reflect some impairment of physiological functioning, could have a negative 
impact on breastfeeding. This is especially true if the newborn is separated from the mother 
in an intensive care unit. While it is possible that these effects of induction and augmentation 
are more related to the underlying reason for induction or augmentation, it has been found 
that the severity of the reason for induction was not related to the differences in neonatal 
outcomes between spontaneous and induced groups, suggesting that the differences between 
these groups was more likely to be an effect of induction (Ounsted et al., 1978). Similarly, 
another study found that a low 1-minute Apgar score was more common after elective 
induction than non-elective induction (Beebe et al., 2007); if the lower Apgar scores had 
been a result of the antenatal conditions requiring non-elective induction, it would be 
expected that low Apgar scores would be more common in the non-elective group. The fact 
that the opposite was true in the study suggests that the adverse neonatal outcomes are not 
merely a result of some pre-existing condition, but are, in fact, related to the induction itself.  
  Pitocin can also have effects on the mother that can potentially interfere with 
breastfeeding. First, exogenous oxytocin may cause desensitization or downregulation of 
OTRs. Studies have found that in vitro, OTR responsiveness decreases with prolonged 
exposure to oxytocin. In one such study, cells were isolated from myometrial tissue samples 
obtained from women undergoing a C-section and were then exposed to oxytocin for 1-6 
hours. Cell response to oxytocin was tested using calcium fluorescence techniques to 
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measure the rise of intracellular calcium levels. The authors found that exposure to oxytocin 
inhibited cells responsiveness time-dependently; while 3 hours of exposure to oxytocin 
resulted in almost no inhibition, responsiveness decreased thereafter until full inhibition was 
reached at 6 hours (Robinson et al., 2003). Therefore, prolonged exposure to a continuous IV 
drip of Pitocin could have an effect on the body’s responsiveness to Pitocin or endogenous 
oxytocin, in which case greater doses of Pitocin may be required.  
Although desensitization of OTRs is more difficult to study in vivo, evidence from 
one study suggests that OTR desensitization does occur in women exposed to exogenous 
oxytocin for labor induction or augmentation (Phaneuf et al., 2000). Using a cross-sectional 
study design, authors compared the number and sensitivity of OTRs from myometrial 
samples taken from women before the onset of labor, after onset of spontaneous labor, or 
after induced or augmented labor. While results indicated that receptor desensitization occurs 
in both spontaneous and induced or augmented labors, there was a significant decrease in 
oxytocin binding in relation to the duration of oxytocin infusion, and there was a much lower 
concentration of oxytocin mRNA following induced labor than spontaneous labor. Because 
of the cross-sectional design of the study, it cannot be known with certainty that the 
desensitization was a direct result of oxytocin infusion, but the fact that oxytocin binding 
decreased as a function of the duration of infusion suggests that it was a result of the 
infusion. There is little, if any, research on desensitization of OTRs in mammary glands, but 
given that desensitization does occur in myometrial tissue, it is presumable that oxytocin 
infusion also causes desensitization in mammary tissue. This could impact breastfeeding after 
birth by inhibiting the oxytocin-induced milk ejection reflex.  
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Additionally, Pitocin can have antidiuretic effects on the mother, potentially leading 
to breast engorgement, which can have a negative impact on breastfeeding. Oxytocin and 
Pitocin molecules resemble vasopressin, a hormone that is also produced in the 
hypothalamus and released from the posterior pituitary. Vasopressin is an antidiuretic 
hormone acting on receptors in the kidney, and because of their similar structure, oxytocin 
and Pitocin can also bind to these receptors to produce an antidiuretic effect. Because Pitocin 
is often administered in relatively high doses, it can lead to breast engorgement, which 
interferes with breastfeeding by making it more difficult for the breast to conform to the 
baby’s mouth and for the baby to adequately latch on to the breast (Cotterman, 2004).  
Another way that Pitocin could impact breastfeeding success is that it can increase the 
stress felt by the mother during labor. The stronger and more painful contractions produced 
by the drug can lead to greater anxiety (Kroeger, 2004), and according to Genazzani et al. 
(1985), clinical observations have suggested that induction of labor leads to “tocophobia,” or 
anxiety and fear of childbirth, which may be related to the lower ß-endorphin levels in 
augmented labor observed in Genazzani et al.’s (1985) study. In addition, research suggests 
that oxytocin infusion during labor interacts with the body’s stress response system, as one 
study found that oxytocin infusion elevates the reactivity of the hypothalamic-pituitary-
adrenal (HPA) axis, which controls the stress response (Jonas, 2009). Further evidence shows 
that these effects can impact breastfeeding. For example, numerous studies have found an 
association between the stress felt by the mother during labor and delivery and delayed onset 
of lactogenesis (reviewed in Matias et al., 2010). Second, stress during labor and delivery can 
also make the infant weaker or more tired (Dewey et al., 2001), which could presumably 
impact motivation and ability to breastfeed. Thus Pitocin can have a negative effect on 
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breastfeeding not only by increasing the stress felt by the mother during labor, but also by 
disrupting the natural physiological response to this stress. 
 
Literature Review: Associations Between Pitocin and Breastfeeding Outcomes 
Studies specifically examining the association between labor induction or 
augmentation and breastfeeding outcomes have had somewhat varying results, but evidence 
tends to suggest that induction and augmentation can have a negative impact on 
breastfeeding. In some studies, the outcome variable is simply whether or not mothers are 
breastfeeding following labor. For example, Yudkin et al. (1979) conducted a retrospective 
study analyzing breastfeeding rates at hospital discharge in mothers with spontaneous 
deliveries compared with those who were induced, primarily by oxytocin infusion, and the 
authors found no significant difference in the proportion of women breastfeeding at discharge 
between the two groups. Similarly, Cartwright (1979) found that women who were induced 
had similar rates of breastfeeding as those who were not induced. However, both of these 
studies also included women who were induced by artificial rupture of the membranes 
(ARM), in which the membranes of the amniotic sac are ruptured to induce labor, so it is 
possible that the studies would have found significant results if only women induced with 
Pitocin were included in the study.  
In a similar study, Jordan et al. (2009) analyzed the Cardiff Birth Cohort to compare 
breastfeeding rates at 48 hours after birth in women given oxytocin infusion with those who 
had received no oxytocin. The authors did not find a significant effect of oxytocin given for 
induction or augmentation on breastfeeding at 48 hours. However, women who had received 
oxytocin during the third stage of labor for the prevention of postpartum hemorrhage were 
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significantly less likely to be breastfeeding at 48 hours, suggesting that exogenous oxytocin 
can have an effect on breastfeeding. Furthermore, the authors excluded from their analysis 
any infants with Apgar scores less than 4. As previously discussed, low Apgar scores are 
associated with Pitocin administration and can affect breastfeeding. Although a low Apgar 
score could be caused by something unrelated to Pitocin, such as a pre-existing condition, 
excluding those infants eliminates some subjects that may have exhibited an association 
between Pitocin and breastfeeding, potentially altering the findings of the study.  
Other studies have found a significant association between Pitocin and breastfeeding. 
A secondary analysis of the WHO Global Survey for Maternal and Perinatal Health found 
that induction led to an increased risk of delayed initiation of breastfeeding (Guerra et al.,  
2009). Although this study also included subjects who were induced by means other than 
intravenous Pitocin, the authors state that the majority of inductions were performed using 
Pitocin or other form of synthetic oxytocin. Similarly, Ounsted et al. (1978) found that 
although all mothers in their study had similar intentions to breastfeed, significantly more 
women who were induced switched to bottle-feeding while still in the hospital or soon after 
discharge. Interestingly, the differences between groups were only significant when the 
authors combined the various methods of induction (oxytocin or prostaglandins) and were 
not significant when they compared each induction group individually with the spontaneous 
group (e.g. oxytocin vs. spontaneous). However, this may have been due to the smaller 
sample sizes when each group was compared individually.  
Out et al. (1988) found that women whose labors were electively induced with Pitocin 
were more likely than those with spontaneous labor to give up their intention to breastfeed 1-
2 months after delivery, although women with medically induced or augmented labors did 
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not show the same effect. The authors suggest that one possible explanation for this finding 
has to do with motivational factors, such that the women who chose to be electively induced 
had less trust in the natural ability of their bodies to initiate labor and to nourish their infants. 
This idea is supported by another study that found psychological differences between 
mothers who were electively induced and those with spontaneous onset (reviewed in Out et 
al., 1988). Also, certain physiological factors that lead to the spontaneous onset of birth may 
also prepare the body for breastfeeding, so mothers who are electively induced may be less 
physiologically prepared to nurse and thus have difficulty after labor (Out et al., 1988).   
All of the above studies used a binary outcome variable of whether or not mothers 
were breastfeeding. Other studies, however, have used outcome variables that measure more 
specific aspects of breastfeeding. Dewey et al. (2003) assessed breastfeeding success in 
dyads from northern California using the Infant Breastfeeding Assessment Tool (IBFAT), 
which assigns a score based on newborn arousal, rooting behavior, time required to latch and 
feed well, and suckling abilities. Any infant with an IBFAT score of ≤10 (out of 12) was 
defined as having Suboptimal Infant Breastfeeding Behavior (SIBB). Another measure of 
breastfeeding was delayed onset of lactogenesis (OL), defined as the mother not perceiving 
fuller breasts by 3 days postpartum. Labor augmentation with Pitocin was not significantly 
associated with SIBB on day 0, 3, or 7, although the trend was that the percentage of infants 
with SIBB on each of the three days was somewhat higher in the augmentation group. 
Augmentation was, however, significantly associated with delayed OL, indicating that 
Pitocin can influence breastfeeding success. This study only included labors that were 
augmented but not induced, though, so it is not known whether that would have had an 
association with SIBB or delayed OL.  
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Matias et al. (2010) conducted a nearly identical study in a population of Peruvian 
primiparous mothers. The results were the same; augmentation of labor with Pitocin was 
significantly associated with delayed OL, though the association between Pitocin and SIBB 
did not reach significance. The authors suggest that the delayed OL may have been related to 
the amount of stress felt by mother and infant during labor, as augmentation was the only 
variable associated with low Apgar score, which can reflect fetal stress during labor. In 
contrast to the results of Dewey et al. (2003) and Matias et al. (2010), however, Chapman 
and Perez-Escamilla (1999) found that induction of labor with oxytocin was not significantly 
associated with delayed OL.  
Finally, Jonas et al. (2009) studied plasma oxytocin levels in women who received 
Syntocinon either intravenously for labor augmentation or intramuscularly for prevention of 
post-partum hemorrhage (PPH). Between 24 and 48 hours after delivery, the infant was 
placed skin-to-skin on the mother’s chest, and blood samples were taken at regular intervals 
once the infant began suckling. Results showed that women who had received intravenous 
oxytocin during labor had lower median plasma oxytocin levels during breastfeeding, with a 
negative correlation between the dose of Syntocinon and plasma levels of oxytocin during 
the sampling period (i.e. the greater the dose of Syntocinon, the lower the endogenous levels 
of oxytocin). According to the authors, these results suggest that exogenous oxytocin 
administered during labor does interfere with natural feedback mechanisms that control the 
release of oxytocin, and this effect lasts for at least two days after delivery.  
 Although some studies have not found a significant effect of labor induction or 
augmentation on breastfeeding, the evidence overall suggests that induction or augmentation 
of labor can negatively influence breastfeeding (Table 1). 
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Table 1. Summary of Literature Review 
Study Results Sig. Effect of 
Induction or 
Augmentation? 
Ounsted et al., 1978 - Induced mothers were more likely to switch to 
bottle-feeding 
Yes 
Guerra et al., 2009 - Induction associated w/delayed initiation of 
breastfeeding 
Yes 
Jonas et al., 2009 - IV oxytocin during labor associated w/lower 
plasma oxytocin levels 24-48 hrs postpartum 
Yes 
Out et al., 1988 - Elective induction associated with lower 
breastfeeding rates 1-2 months after delivery 
- Medical induction & augmentation had no effect 
on breastfeeding rates 
Yes and No 
Dewey et al., 2003 
& Matias et al., 2010 
- Augmentation associated with delayed onset of 
lactogenesis  
- Labor augmentation not associated with SIBB on 
day 0, 3, or 7 
Yes and No 
Jordan et al., 2009 - Women given oxytocin during 3rd stage of labor 
had lower breastfeeding rates 
- Breastfeeding rates at 48 hours similar among 
women given oxytocin infusion during labor and 
those without it 
Yes and No 
Cartwright, 1979 - Induced and spontaneous mothers had similar 
rates of breastfeeding 
No 
Yudkin et al., 1979 - At hospital discharge, mothers with induction and 
spontaneous labor had similar breastfeeding rates  
No 
Chapman and Perez-
Escamilla, 1999 
- Labor induction was not associated with delayed 
onset of lactogenesis  
No 
 
 
The Importance of Breastfeeding 
Exclusive breastfeeding has numerous benefits for infants, including lower morbidity 
and mortality, lower incidence of diarrhea, lower blood pressure and cholesterol levels later 
in life (Bai et al., 2009), reduced risk of developing allergies like asthma, and enhanced 
immune protection against various illnesses, such as respiratory diseases, ear infections, 
colds, viruses, and SIDS, as well as cognitive benefits. Breastfeeding also provides benefits 
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for the mother, including lower risk of developing type 2 diabetes later in life and reduced 
likelihood of breast and ovarian cancer (“La Leche,” 2011). Furthermore, a recent study 
calculated that based on the costs of treating health problems associated with non-exclusive 
breastfeeding, the U.S. would save $13 billion per year and prevent 911 excess deaths 
(primarily infant deaths) if 90% of infants were exclusively breastfed for six months (Bartick 
& Reinhold, 2010).   
The establishment of successful breastfeeding in the first days following birth is 
critical. First, if a mother and newborn encounter problems breastfeeding early on, the 
newborn may not receive enough milk and therefore experience excessive weight loss, 
dehydration, and other complications (Dewey et al., 2003). Studies have also shown that 
breastfeeding problems shortly after birth, such as poor positioning and ineffective sucking 
and latch, are associated with shorter overall duration of breastfeeding (Kronborg and Vaeth, 
2009; Santo et al., 2007; Cernadas et al., 2003). Breastfeeding problems within the first week 
after birth is even associated with decreased likelihood of successful breastfeeding with 
subsequent children (reviewed in Dewey et al., 2003). Furthermore, Chapman and Perez-
Escamilla (1999) found that among women who intended to breastfeed for longer than 6 
months, those who had delayed OL had significantly shorter breastfeeding duration than 
mothers with earlier OL. One reason for this finding may be that mothers with delayed OL 
experienced more problems nursing and had less confidence in their ability to produce 
enough milk and were thus more likely to switch to bottle-feeding sooner. 
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Early Breastfeeding Assessment  
A commonly used method to assess breastfeeding after birth is the LATCH scoring 
system. The LATCH score is a 10-point measure modeled after the Apgar score and is often 
used in hospitals and birth centers to identify dyads that need more assistance to establish 
successful breastfeeding (Table 2). The score is based on five dimensions of breastfeeding: 
infant latch (L), audible swallowing (A), type of nipple (T), comfort of breast/nipple (C), and 
hold/positioning (H) (Jensen et al., 1994). LATCH scores have been found to be associated 
with breastfeeding duration (Kumar et al., 2006). In one study, Kumar et al. (2006) measured 
LATCH scores at regular intervals during the first 3 days postpartum and found that at 6 
weeks after birth, mothers who were still breastfeeding their infants had received 
significantly higher LATCH scores 0-48 hours after birth than mothers who were not 
breastfeeding at 6 weeks. The study also found that mothers who had a LATCH score of 9 or 
higher at 16-24 hours postpartum were 1.7 times more likely to still be breastfeeding at 6 
weeks than mothers who had lower scores during that time period. In another study, it was 
found that LATCH score was inversely related to non-exclusive breastfeeding at the time of 
discharge from the hospital, and the mean score of dyads exclusively breastfeeding at 
discharge was significantly higher than the mean score of those who were not exclusively 
breastfeeding (Tornese et al., 2012). These findings all underscore the importance of 
establishing successful breastfeeding in the immediate postpartum period. 
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Aims and Predictions 
To date, there have been no studies examining the association between Pitocin 
administration and LATCH scores. The goal of the present study is to compare LATCH 
scores in women receiving intravenous Pitocin for induction or augmentation of labor with 
those of women who received no Pitocin prior to delivery. The primary aims are as follows:  
- To determine whether Pitocin has an effect on overall LATCH score following 
birth 
- If there is an effect on LATCH score, to determine if Pitocin primarily affects the 
mother, the infant, or both 
- To determine if there is an effect of Pitocin on the infant’s Apgar score, and if so, 
if that leads to lower LATCH score.  
Based on the evidence that Pitocin can lead to adverse neonatal and maternal 
outcomes that can impact breastfeeding, I hypothesize that mother-infant dyads exposed to 
intravenous Pitocin will have significantly lower LATCH scores following birth than dyads 
that were not exposed to Pitocin. I also predict that if, as studies suggest, Pitocin has adverse 
effects on the infant, such as poorer oxygenation and increased stress during labor, the 
“Latch” and “Audible swallowing” components of the LATCH score will be lower in the 
Pitocin group. If Pitocin impacts maternal behaviors or causes the mother greater stress or 
anxiety following birth, I expect to find that the Pitocin group will have lower scores on the 
“Hold” component of the score. Furthermore, because the antidiuretic effects of Pitocin can 
lead to edema and thus breast engorgement (Cotterman, 2004), I expect that mothers who 
received Pitocin will have lower scores on the “Comfort” component of the LATCH score. 
However, I do not expect to see an effect of Pitocin on “Type of nipple.”  
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I will also control for overall condition of the newborn, measured by Apgar score, in 
the analyses as a factor that could influence LATCH scores and potentially interact with the 
effects of synthetic oxytocin to influence breastfeeding success. It is expected that if Pitocin 
impacts LATCH score by negatively affecting the health of the neonate, this would result in a 
significant interaction effect between Pitocin, Apgar and LATCH score.   
Given the life-long health benefits of breastfeeding and the importance of establishing 
successful breastfeeding in the early postpartum period, along with the rising rates of Pitocin 
use in hospitals, the results of this study may have implications for hospital practice in the 
U.S. by identifying dyads that are more at risk for breastfeeding problems and by providing 
more evidence about the impacts of Pitocin use.   
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Methods 
Subjects 
 For this study, retrospective data for mother-infant dyads will be obtained from de-
identified electronic medical records (EMRs) at Loma Linda University Medical Center, a 
large university hospital in southern California. Dyads will be selected based on the 
following criteria: singleton birth, vaginal delivery with no major complications (e.g. 
postpartum hemorrhage, admission to the NICU, etc.), no pain medications given (e.g. 
epidural analgesia), ≥37 weeks gestational age, ≥5.5 lbs birth weight, and exclusive 
breastfeeding. A preliminary power analysis will be conducted to determine the number of 
subjects needed for the study.   
 
Variables 
 The independent variable in this study is the use of Pitocin prior to delivery. All 
mothers in the treatment group will have received intravenous Pitocin for induction or 
augmentation of labor, whereas mothers in the control group will have received no Pitocin or 
other medications prior to delivery.  
 The outcome variable is LATCH score assessed during the first feeding after birth 
(Table 2). At Loma Linda, it is standard protocol for nurses trained in LATCH scoring to 
assess breastfeeding postpartum. The first two dimensions of the LATCH score (latch and 
audible swallowing) are based on the newborn’s behavior, while the other three (type of 
nipple, comfort, and hold) are based on characteristics of the mother. Each dimension has a 
possible score of 0-2 (Table 2), and the overall LATCH score can range from 0-10, with a 
score of 10 representing the most successful breastfeeding. In addition, one covariate that 
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will be used in the study is Apgar score at 1 and 5 minutes, which will be included in the 
analyses in order to determine whether an effect of Pitocin on Apgar score may then 
influence LATCH score. 
 
 
 0 1 2 
L: Latch - Too sleepy or 
reluctant 
- No latch achieved  
- Repeated attempts 
- Hold nipple in mouth 
- Stimulate to suck 
- Grasps breast 
- Tongue down 
- Lips flanged 
- Rhythmic sucking 
A: Audible 
Swallowing 
- None - A few with 
stimulation 
- Spontaneous and 
intermittent < 24 
hours 
- Spontaneous and 
frequent > 24 hours 
old. 
T: Type of 
Nipple 
- Inverted - Flat 
 
- Everted (after 
stimulation) 
C: Comfort 
(Breast/nipple) 
- Engorged 
- Cracked, bleeding, 
large blisters, or 
bruises 
- Severe discomfort 
- Filling 
- Reddened/small 
blisters or bruises 
- Mild/moderate 
discomfort 
- Soft  
- Non-tender 
H: Hold 
(positioning) 
- Full assist (staff holds 
infant at breast) 
- Minimal assist 
- Teach 1 side; mother 
does other 
- Staff holds and then 
mother takes over 
- No assist from staff 
- Mother able to 
position/hold infant 
Table copied from Jensen et al. (1994)  
 
Statistical Analyses 
 Using SPSS statistical software version 19.0, the association between administration 
of Pitocin and LATCH score will be analyzed with a generalized linear model, with an 
ordinal distribution and logistic link. In this model, the ordinal response variable is total 
Table 2. LATCH Scoring System 
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LATCH score of 0-10; predictors are Pitocin administration (yes, no) as a fixed factor, Apgar 
score as an ordinal covariate, and the interaction between Pitocin and Apgar score. 
In addition to the model for the total LATCH score, each of the five dimensions of 
the LATCH score will be analyzed separately using a generalized linear model. In each of 
these models, the ordinal response variable is a score between 0-2 for the various dimensions 
of the LATCH score (e.g. latch, audible swallowing, etc.), and the predictor and interaction 
variables are the same as in the model for total LATCH score.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
30 
Discussion 
Expected Results 
If mother-infant dyads exposed to Pitocin during labor have significantly lower 
overall LATCH scores compared to those not exposed to Pitocin, these results would indicate 
that Pitocin does have an effect on breastfeeding, supporting my hypothesis. However, 
analyzing only the overall LATCH score does not provide information about why Pitocin 
impacts breastfeeding, so it is more useful to compare individual components of the LATCH 
score.  
 
“Latch” 
 The first component of the LATCH score is “Latch,” which measures the infant’s 
ability to latch on to the breast (Table 2). Significantly lower scores on the “Latch” 
component of the LATCH score for infants exposed to intravenous Pitocin compared to those 
that were not would indicate that infants in the Pitocin group tend to have difficulty latching 
on to the breast during breastfeeding, supporting my hypothesis. In order for the neonate to 
establish an adequate latch, it must be able to create enough suction to hold the areola and 
nipple in its mouth, which requires proper oral and facial muscle tone (Radzyminski, 2005). 
The “Latch” component also measures whether the infant displays rhythmic sucking while 
maintaining latch, which requires coordination of sucking, swallowing, and breathing. The 
inability of the newborn to maintain adequate latch and coordination may reflect poor 
neurobehavioral functioning. Several cranial nerves, including the facial and accessory 
nerves, control the muscles involved in latching on to the breast (Radzyminski, 2005), and as 
previously mentioned, it has been suggested that the stronger uterine contractions produced 
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by Pitocin can interfere with the proper functioning of these cranial nerves (Kroeger, 2004). 
In order to achieve adequate latch, the newborn must also be alert and willing to nurse 
(Radzyminski, 2005). It has been suggested that stress to the fetus during labor and/or birth 
can interfere with motivation to breastfeed (Chen et al., 1998) or cause it to be weak and tired 
(Dewey, 2001), which could result in a score of 0 on the “Latch” component if the infant is 
too sleepy or reluctant to latch. Jaundice, which is associated with Pitocin use (Cartwright, 
1979), can also cause an infant to be sleepier (La Leche League International, 2004). 
Moreover, according to clinical observations, newborns with hypoxia, which can result from 
the strong uterine contractions caused by Pitocin, tend to breastfeed poorly (Walker, 1989), 
which could be reflected by a lower “Latch” component score.  
The inability of a newborn to attain adequate latch could also reflect a disorganized 
behavioral state. Newborns normally cycle through various behavioral states, from deep 
sleep to quiet alert to crying, with quiet alert being the ideal state for adequate latch (Karl, 
2004). However, newborns that have trouble regulating their autonomic nervous system, 
which includes heart rate and respiration, may also have difficulty organizing their 
behavioral state and reaching a quiet alert state. Stress and overstimulation can lead to a 
disorganized state characterized by loss of motor organization, decreased muscle tone, or a 
“closedown” reaction, in which the newborn closes its eyes and remains still in order to shut 
out negative stimuli (Karl, 2004). Therefore, because Pitocin use is sometimes associated 
with abnormal heart rate (e.g. bradycardia) (Belsky, 1982; Glantz, 2005) and other stressors 
at the time of delivery (e.g. shoulder dystocia, assisted ventilation) (Romano & Lothian, 
2008), the newborn may then be in a disorganized behavioral state that negatively impacts its 
ability to achieve proper latch.  
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Furthermore, if Pitocin was used for induction of labor (as opposed to augmentation), 
an alternative explanation for a newborn’s inability to establish adequate latch is that the 
newborn may be “near-term” rather than full-term. Even if a fetus’s size and gestational age 
suggest that it is full-term, inducing labor rather than letting it begin spontaneously is more 
likely to result in the birth of a near-term baby. Although a near-term newborn may look 
similar to a full-term infant, it may not be fully mature and may have a less-developed ability 
to latch on to the breast and coordinate sucking and swallowing (Lothian, 2006). Thus a low 
score on the “Latch” component can be explained as a result of a near-term delivery, as well 
as a result of stress felt by the neonate during labor and delivery and poor neurobehavioral 
functioning caused by excessively strong uterine contractions. 
 
“Audible Swallowing” 
 The second component of the LATCH score is “Audible swallowing,” which 
measures whether or not swallowing is heard as a short, forceful expiration of air during 
breastfeeding (Jensen, 1994). Audible swallowing is the main indicator of milk intake and 
indicates that the milk ejection reflex has occurred (Jensen, 1994). A lower score on this 
component would suggest that the infant is not adequately taking in milk, which could be a 
result of inadequate suckling technique, such as poor coordination of sucking, swallowing, 
and breathing or the inability to compress the areolar tissue in order to express milk from the 
breast. A lack of milk expression could also indicate a problem with the milk ejection reflex; 
as previously discussed, the primary role of oxytocin in breastfeeding is stimulating the 
alveoli within the breast to contract and eject milk into ducts in response to suckling. If, as 
hypothesized, dyads exposed to Pitocin have significantly lower “Audible swallowing” 
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scores, this could suggest that Pitocin affects the infant’s ability to properly grasp the breast 
and coordinate sucking and swallowing in order to take in milk in the same ways that it could 
affect its ability to maintain adequate latch, as discussed above. A lower “audible 
swallowing” score could also mean that Pitocin interferes with maternal release of oxytocin, 
which stimulates the milk ejection reflex. This would be consistent with the finding that 
mothers exposed to Pitocin had lower levels of endogenous oxytocin released during 
breastfeeding 24-48 hours after birth (Jonas et al., 2009). Alternatively, animal studies have 
shown that the stress response can interfere with milk ejection (e.g. by vasoconstriction 
within the mammary glands) (reviewed in Lau, 2001), and because intravenous Pitocin has 
been found to increase the reactivity of the HPA axis involved in the stress response (Jonas, 
2009), the milk ejection reflex of mothers who received Pitocin may be affected by this 
heightened reactivity of their stress response. If this were the case, the infant may not receive 
as much milk during feeding and would thus not exhibit audible swallowing.   
 
“Comfort of Breast/Nipple”  
 The fourth component of the LATCH score is “Comfort of the breast/nipple,” which 
is hypothesized to be significantly lower in women exposed to Pitocin. Breast engorgement, 
mild to severe overall discomfort when nursing, nipples with redness, small to large blisters 
or bruises, cracking or bleeding will result in a “Comfort” score of only 0 or 1. Soreness or 
other problems with the nipple can result from improper infant latch and sucking – for 
example, if the nipple is sucked in rather than placed far back in the baby’s mouth (La Leche 
League International, 2004). Thus, if this were the reason for lower scores on “Comfort,” it 
would be expected that the “Latch” component score would also be lower. Another possible 
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reason for a lower “Comfort” score is breast engorgement related to the antidiuretic 
properties of oxytocin and Pitocin (Cotterman, 2004). While naturally-produced oxytocin can 
produce this effect, the somewhat higher levels of Pitocin administered during labor 
induction or augmentation may be more likely to cause edema and breast engorgement, thus 
resulting in a lower “Comfort” score.   
 
“Hold” 
The “Hold” component of the LATCH score assesses how well the mother holds her 
infant during breastfeeding, and its main purpose is to determine how much assistance and 
teaching the mother requires from hospital staff (Jensen, 1994). If the mother is not able to 
position and hold her infant without help from staff, she will receive a lower score. If the 
hypothesis that the “Hold” component of the LATCH score would be lower in the Pitocin 
group is supported, there are several possible explanations for this finding. First, as discussed 
previously, it may be possible that when labor does not begin on its own, there is a difference 
in the amount of oxytocin released within the brain compared to spontaneous labor. Because 
oxytocin is known to influence maternal behavior, if a mother has lower levels of oxytocin 
released within the central nervous system as a result of labor induction, her own maternal 
behaviors may be impacted in such a way that she is less able to position and hold her infant 
on her own during breastfeeding, especially if she has had no prior experience breastfeeding.  
A second explanation for a lower “Hold” score in the Pitocin group is that these 
women have less confidence in their ability to nurse their infants as a result of induction or 
augmentation and thus require greater assistance to hold and position the newborn. One study 
of women’s breastfeeding self-efficacy in the immediate postpartum period, which is related 
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to overall duration of breastfeeding, found that a woman’s sense of control during labor and 
her satisfaction with pain relief were correlated with her breastfeeding self-efficacy, and 
mothers with more interventions during labor and delivery had lower self-efficacy scores 
(Dennis, 2006). Because Pitocin often causes stronger, more frequent, and more painful 
uterine contractions, a woman whose labor is induced or augmented may feel less control and 
greater pain during labor, thus reducing her sense of breastfeeding self-efficacy and causing 
her to require greater assistance to hold and position the infant, resulting in a lower “Hold” 
score.   
 
Apgar Score 
 If the interaction between Pitocin and Apgar score is found to significantly affect 
LATCH score, as hypothesized, this would indicate that Pitocin affects the health of the 
infant, reflected in the Apgar score, in a way that negatively impacts breastfeeding ability. 
For example, as previously discussed, Pitocin has been found to be associated with fetal 
acidosis (Bakker et al., 2007), bradycardia (Belsky, 1982; Glantz, 2005), and neonatal 
resuscitation (Romano and Lothian, 2008). These outcomes could result in a lower Apgar 
score and thus LATCH score, as lower Apgar scores can be associated with breastfeeding 
problems (Dewey et al., 2003; Matias et al., 2010). Alternatively, if labor is induced when 
the fetus is near-term rather than full-term, it could be less developmentally prepared for 
extrauterine life, which could result in both a lower Apgar score and a lower LATCH score. 
On the other hand, if a medical condition of the fetus necessitated induction of labor with 
Pitocin, both low Apgar and LATCH score could be results of the antenatal condition leading 
to induction rather than results of Pitocin itself. While some studies control for Apgar score 
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by excluding from analyses infants with low scores, analyzing the interaction between 
Pitocin and Apgar score as a predictor of LATCH score provides a way to determine if poor 
neonatal health following birth, as measured by Apgar score, helps explain lower LATCH 
score.     
  
Alternative Results 
 The third component of the LATCH score is “Type of nipple,” with flat or inverted 
nipples receiving a lower score than everted nipples. It is hypothesized that Pitocin would not 
have an effect on “Type of nipple” score, because inverted nipples are often caused by 
adhesions binding the skin of the nipple and areola to the underlying tissue (Smith, 2012), 
which is unlikely to be related to Pitocin use. However, if scores for this component are 
found to be lower in women who received Pitocin, one possible explanation is breast 
engorgement. As mentioned, the antidiuretic effects of Pitocin can lead to fluid retention and 
breast engorgement, which can then result in flat nipples that do not protrude when 
stimulated during breastfeeding (“Flat and Inverted Nipples,” 2011) and thus a score of 1 on 
the “T” component of the LATCH score. 
 It is also possible that this study will not find a significant association between Pitocin 
administration and overall LATCH score. If this were the case, a possible explanation would 
be that, contrary to my hypothesis, Pitocin did not affect the dyads in the study sample in a 
way that interferes with breastfeeding. On the other hand, it is possible that Pitocin affects 
breastfeeding in ways not measurable by the LATCH scoring system. For example, studies 
have found that labor augmentation with Pitocin is significantly associated with delayed OL 
(Dewey et al., 2003; Matias et al., 2010), but because OL does not occur until around 3 days 
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postpartum, LATCH scores assessed within the first several hours following birth would not 
measure delayed OL.  
 Another explanation for lack of a significant association between Pitocin and LATCH 
score could be related to the fact that Loma Linda University Medical Center is a Baby 
Friendly Hospital. Hospitals with the UNICEF/WHO Baby Friendly designation demonstrate 
routine practices known to promote breastfeeding, including giving the infant no food or 
drink other than breastmilk unless medically indicated and allowing the mother and infant to 
remain in the same room together 24 hours a day. Therefore, some of the potentially negative 
effects of Pitocin on breastfeeding may be mitigated by these practices that are designed to 
promote optimal breastfeeding. Future studies should look at data from hospitals without the 
Baby Friendly designation and with lower breastfeeding rates than Loma Linda, where 
potentially small effects of Pitocin could have a greater impact on breastfeeding since 
mothers are not receiving as much breastfeeding support.  
 Another explanation for a finding of no association between Pitocin and LATCH 
score is that at Loma Linda, like many hospitals in the U.S., it is routine practice for mothers 
to receive an intramuscular injection of Pitocin following delivery for PPH. Jordan et al. 
(2009) found that the use of Pitocin after delivery for this purpose was associated with lower 
breastfeeding rates at 48 hours. Therefore, even if Pitocin given for PPH does have a 
negative effect on LATCH score, there would not be a significant difference between the 
control and Pitocin groups if all mothers are given Pitocin for PPH. Future studies should 
obtain data from control groups that have not been exposed to Pitocin for PPH in order to 
control for the possible confounding effects of this routine practice.  
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 If, contrary to my hypothesis, LATCH scores are significantly lower in the Pitocin 
group without a significant interaction between Pitocin and Apgar score, this could indicate 
that lower LATCH scores have more do with characteristics of the mother, such as breast 
engorgement. Or, it could mean that the cause of the infant’s difficulty breastfeeding is not 
measured by Apgar score. For instance, sleepiness resulting from jaundice or a problem with 
the cranial nerves controlling muscles used in latching on would not be likely to result in a 
lower Apgar score, even though they could result in lower LATCH score.  
 Although unlikely, it is possible that mothers receiving Pitocin will have higher 
LATCH scores than the control group, contrary to my hypothesis. One conceivable 
explanation is that the stronger and more frequent contractions caused by Pitocin somehow 
stimulate a greater release of oxytocin from the posterior pituitary via the Fergusson reflex 
and that higher levels continue to be released even after birth in response to suckling. This 
could then stimulate the milk ejection reflex, which would most likely result in a higher 
“Audible swallowing” score, as discussed above. This would, however, be inconsistent with 
Jonas et al.’s (2009) finding that women exposed to intravenous oxytocin had lower 
circulating levels of oxytocin during breastfeeding 24-48 hours postpartum. It could also be 
possible that the higher circulating levels of Pitocin during labor resulting from induction or 
augmentation compared to circulating levels of oxytocin during spontaneous labor somehow 
enhances the milk ejection reflex after birth, although this, too, would be unlikely given that 
the half-life of oxytocin (and thus Pitocin) in circulation is only 1-2 minutes (Jonas, 2009). 
Finally, although the blood-brain barrier prevents oxytocin/Pitocin from entering the brain, 
higher LATCH scores in the Pitocin group could result from a very small percentage of 
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Pitocin reaching the brain from the peripheral circulation and stimulating release of oxytocin 
into circulation or enhancing maternal behaviors. 
 
Future Studies 
 There are many possibilities for future studies to further investigate the impact of 
labor induction on breastfeeding. For example, because previous studies have found that 
there are sex differences in neonatal response to certain stressors (Davis and Emory, 1995), it 
would be interesting to study whether there is a sex difference for the effects of Pitocin on 
the neonate. Future studies could also investigate whether there is a difference in the effect of 
Pitocin on breastfeeding between primiparas and multiparas; it would make sense that 
because multiparas have likely had prior experience breastfeeding, they would be less 
susceptible to some of the potentially negative effects of Pitocin and would have higher 
LATCH scores, especially for the “Hold” component. And although it is not possible in the 
proposed study to determine solely from the electronic medical records whether Pitocin is 
given for induction or for augmentation, future studies that have access to this information 
should investigate whether there is a difference in the effects of Pitocin on LATCH score 
between induced and augmented labors. A finding that LATCH scores are lower when labor 
is induced compared to when it is augmented would suggest that the adverse effects are 
because the mother and/or infant are less physiologically and developmentally prepared for 
breastfeeding (e.g. the neonate is “near-term” rather than full-term).  
 Future studies should also examine the interaction between Pitocin and other drugs 
commonly administered during labor, such as epidural for pain management. Many studies 
have found that epidurals have adverse effects on breastfeeding, so it would be important to 
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further investigate the combined effects of Pitocin and other drugs. Finally, because there is 
minimal research on the direct effects of Pitocin on maternal behavior, this is another area for 
future study. Although the “Hold” component of the LATCH score provides some measure 
of maternal behavior, futures studies should explore other aspects of maternal behavior to 
determine whether Pitocin interferes with the role of endogenous oxytocin in facilitating 
maternal behaviors following birth.  
 
Implications 
 Given the widespread and routine use of Pitocin in hospitals across the U.S., the 
results of this study will have broad implications for maternal and neonatal health. Although 
there are many known health benefits of breastfeeding, less than half of mothers in the U.S. 
breastfeed exclusively for the first six months as recommended by the American Academy of 
Pediatrics and the World Health Organization (Bai et al., 2009). Therefore, it is even more 
important to identify factors that can have adverse effects on breastfeeding. Even though this 
study will only look at breastfeeding success immediately following birth, mothers who 
experience problems at this early stage may have less confidence in their ability to breastfeed 
and may be more likely to give up breastfeeding sooner if they do not receive adequate 
support to resolve early problems.  
 The results of this study will have practical applications in clinical settings. First, if 
Pitocin is found to be associated with lower LATCH scores, this knowledge would help 
hospital staff identify dyads that are more at-risk for breastfeeding problems and may need 
extra support to ensure the establishment of successful breastfeeding routines. Second, if 
Pitocin is found to be associated with poorer breastfeeding outcomes, it would be an 
41 
important factor to consider when mothers and health care professionals are deciding whether 
or not to use Pitocin. There certainly are instances in which the use of Pitocin is medically 
necessary and the benefits outweigh the potential risks. However, induction and 
augmentation with Pitocin has become a nearly routine practice in many hospitals and is 
often done without real medical necessity. For example, the Listening to Mothers II survey 
found that a maternal health problem was a reason for induction less than 20% of the time, 
and concern for the baby’s health was cited as a reason less than 10% of the time (Declercq 
et al., 2006). Hospitals must reevaluate their practices in order to prevent the overuse of 
interventions like intravenous Pitocin that have the potential to be detrimental to both the 
short- and long-term health of the mother and infant. 
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